World News: 22:15 GMT Wednesday 16th May 2018. [Dynavax Technologies Corporation via Globe Newswire via SPi World News]
BERKELEY Calif May 16 2018 GLOBE NEWSWIRE -- Dynavax Technologies Corporation NASDAQDVAX announced today that data will be presented from its ongoing Phase 1b2 study investigating SD-101 Dynavaxs intratumoral TLR9 agonist, in combinati on with...
Globe Newswire: 22:15 GMT Wednesday 16th May 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.